238 related articles for article (PubMed ID: 3514094)
1. Multiple sclerosis: neuroimmunologic puzzle.
Barna BP
Clin Lab Med; 1986 Mar; 6(1):103-16. PubMed ID: 3514094
[TBL] [Abstract][Full Text] [Related]
2. Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Mars LT; Saikali P; Liblau RS; Arbour N
Biochim Biophys Acta; 2011 Feb; 1812(2):151-61. PubMed ID: 20637863
[TBL] [Abstract][Full Text] [Related]
3. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion.
Raine CS
Ann Neurol; 1994; 36 Suppl():S61-72. PubMed ID: 8017891
[TBL] [Abstract][Full Text] [Related]
4. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic usefulness of cerebrospinal fluid in multiple sclerosis.
Mehta PD
Crit Rev Clin Lab Sci; 1991; 28(3):233-51. PubMed ID: 1905549
[TBL] [Abstract][Full Text] [Related]
6. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
7. Immunology of multiple sclerosis.
Pender MP; Greer JM
Curr Allergy Asthma Rep; 2007 Jul; 7(4):285-92. PubMed ID: 17547851
[TBL] [Abstract][Full Text] [Related]
8. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.
Beseler C; Vollmer T; Graner M; Yu X
PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
10. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Otto C; Hofmann J; Ruprecht K
Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
[TBL] [Abstract][Full Text] [Related]
11. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
Sobottka B; Harrer MD; Ziegler U; Fischer K; Wiendl H; Hünig T; Becher B; Goebels N
Am J Pathol; 2009 Sep; 175(3):1160-6. PubMed ID: 19700745
[TBL] [Abstract][Full Text] [Related]
12. Oligoclonal bands and antibody responses in multiple sclerosis.
Correale J; de los Milagros Bassani Molinas M
J Neurol; 2002 Apr; 249(4):375-89. PubMed ID: 11967640
[TBL] [Abstract][Full Text] [Related]
13. Pathology and etiology in multiple sclerosis: a review.
Kraft AM; Wessman HC
Phys Ther; 1974 Jul; 54(7):716-20. PubMed ID: 4608763
[No Abstract] [Full Text] [Related]
14. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
Stinissen P; Raus J; Zhang J
Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
[TBL] [Abstract][Full Text] [Related]
15. Preclinical model of multiple sclerosis: Methods in autoimmune demyelination.
Nissen JC; Tsirka SE
Methods Cell Biol; 2022; 168():67-86. PubMed ID: 35366992
[TBL] [Abstract][Full Text] [Related]
16. Insights into the immunopathogenesis of multiple sclerosis.
Hellings N; Raus J; Stinissen P
Immunol Res; 2002; 25(1):27-51. PubMed ID: 11868933
[TBL] [Abstract][Full Text] [Related]
17. Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination.
Rifai N; Christenson RH; Gelman BB; Silverman LM
Clin Chem; 1987 Jul; 33(7):1155-7. PubMed ID: 3594843
[TBL] [Abstract][Full Text] [Related]
18. [Immunological abnormalities in multiple sclerosis].
Tabira T
No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
[No Abstract] [Full Text] [Related]
19. Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target.
Liu R; Du S; Zhao L; Jain S; Sahay K; Rizvanov A; Lezhnyova V; Khaibullin T; Martynova E; Khaiboullina S; Baranwal M
Front Immunol; 2022; 13():996469. PubMed ID: 36211343
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo models of multiple sclerosis.
van der Star BJ; Vogel DY; Kipp M; Puentes F; Baker D; Amor S
CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):570-88. PubMed ID: 22583443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
